TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

CAMAPS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

CAMAPS

ST13

US500000079347237

Classe

9, 42

Pedido

79347237

Registro

7312289

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

28

Atualização mais recente

20/07/2024

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9, 42

Data de depósito

14/06/2022

Data de registro

27/02/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

27/02/2024

Última transação

27/02/2024

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

GB

Examinador

EDWARDS, ALICIA COLLINS

Unidade examinadora

M60

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

CamDiab Ltd

Representantes

Sean K. Owens Wood Herron & Evns LLP

Classificação técnica

Classes Nice

Classe 9Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Computer software, namely, downloadable computer software for providing live data regarding glucose readings from sensors, for alerting and remote monitoring based glucose readings and other signals, for tracking and regulating insulin delivery by insulin pump, and for the automated insulin delivery for use in the field of treatment and management of diabetes and related conditions; computer software, namely, downloadable computer software for providing live data regarding glucose readings from sensors, for alerting and remote monitoring based glucose readings and other signals, for tracking and regulating insulin delivery by insulin pump, and for the automated insulin delivery for use in the medical field; mobile application software, namely, downloadable mobile application software for providing live data regarding glucose readings from sensors, for alerting and remote monitoring based glucose readings and other signals, for tracking and regulating insulin delivery by insulin pump, and for the automated insulin delivery for use in the field of treatment and management of diabetes and related conditions; mobile software applications, namely, downloadable mobile software applications for providing live data regarding glucose readings from sensors, for alerting and remote monitoring based glucose readings and other signals, for tracking and regulating insulin delivery by insulin pump, and for the automated insulin delivery for use in the field of medical technology

Classe 42

Design and development of computer software; design and development of computer software for use with medical technology; Software as a Service (SaaS) services featuring software for providing live data regarding glucose readings from sensors, for alerting and remote monitoring based glucose readings and other signals, for tracking and regulating insulin delivery by insulin pump, and for the automated insulin delivery for use in the field of treatment and management of diabetes and related conditions; Software as a Service (SaaS) services featuring software for providing live data regarding glucose readings from sensors, for alerting and remote monitoring based glucose readings and other signals, for tracking and regulating insulin delivery by insulin pump, and for the automated insulin delivery for use in the fields of healthcare and medicine; design and development of software in the field of mobile applications; Electronic data storage

Publicações

Histórico de despachos e eventos da marca no USPTO.

28 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

20/07/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/07/2024

FIMP

FINAL DISPOSITION PROCESSED

01/07/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

28/05/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

27/02/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

27/02/2024

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

05/02/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

17/01/2024

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

17/01/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/12/2023

PUBO

PUBLISHED FOR OPPOSITION

12/12/2023

GPNX

NOTIFICATION PROCESSED BY IB

11/12/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

22/11/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

22/11/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

22/11/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/11/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/10/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/10/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/10/2023

RFNT

REFUSAL PROCESSED BY IB

06/06/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

15/05/2023

RFRR

REFUSAL PROCESSED BY MPU

15/05/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

28/03/2023

CNRT

NON-FINAL ACTION WRITTEN

27/03/2023

DOCK

ASSIGNED TO EXAMINER

27/03/2023

MAFR

APPLICATION FILING RECEIPT MAILED

16/08/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/08/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/08/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace CAMAPS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.